Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cocaine | 70 | 2015 | 961 | 5.940 |
Why?
|
Cocaine-Related Disorders | 16 | 2015 | 460 | 2.570 |
Why?
|
Saimiri | 92 | 2019 | 334 | 2.510 |
Why?
|
Self Administration | 37 | 2019 | 390 | 2.460 |
Why?
|
Behavior, Animal | 46 | 2010 | 1857 | 2.230 |
Why?
|
Dopamine Agonists | 18 | 2009 | 352 | 1.920 |
Why?
|
Narcotics | 11 | 2009 | 336 | 1.760 |
Why?
|
Discrimination Learning | 22 | 2010 | 278 | 1.710 |
Why?
|
Conditioning, Operant | 30 | 2015 | 308 | 1.690 |
Why?
|
Heroin | 9 | 2009 | 117 | 1.510 |
Why?
|
Receptors, Dopamine D2 | 13 | 2010 | 485 | 1.510 |
Why?
|
Dopamine Uptake Inhibitors | 18 | 2015 | 297 | 1.480 |
Why?
|
Receptors, Dopamine D1 | 13 | 2010 | 293 | 1.430 |
Why?
|
Behavior, Addictive | 9 | 2019 | 462 | 1.380 |
Why?
|
Reinforcement Schedule | 28 | 2011 | 123 | 1.310 |
Why?
|
Receptors, Opioid, mu | 7 | 2019 | 166 | 0.910 |
Why?
|
Receptors, Metabotropic Glutamate | 4 | 2012 | 196 | 0.880 |
Why?
|
Dose-Response Relationship, Drug | 57 | 2019 | 10825 | 0.750 |
Why?
|
Receptors, Dopamine | 8 | 2008 | 292 | 0.710 |
Why?
|
Dopamine Antagonists | 10 | 2004 | 288 | 0.700 |
Why?
|
Extinction, Psychological | 8 | 2015 | 371 | 0.700 |
Why?
|
Receptors, Dopamine D3 | 3 | 2010 | 107 | 0.690 |
Why?
|
Naltrexone | 8 | 2009 | 315 | 0.630 |
Why?
|
Anti-Anxiety Agents | 9 | 2002 | 397 | 0.610 |
Why?
|
Norepinephrine | 4 | 2010 | 899 | 0.600 |
Why?
|
Receptors, Opioid | 5 | 2007 | 145 | 0.580 |
Why?
|
Triazolam | 5 | 2002 | 16 | 0.550 |
Why?
|
Glycine Plasma Membrane Transport Proteins | 2 | 2012 | 21 | 0.520 |
Why?
|
GABA Agonists | 6 | 2005 | 105 | 0.490 |
Why?
|
Piperazines | 15 | 2009 | 2516 | 0.480 |
Why?
|
Excitatory Amino Acid Antagonists | 3 | 2008 | 447 | 0.470 |
Why?
|
Injections, Intravenous | 15 | 2009 | 1384 | 0.470 |
Why?
|
Chlordiazepoxide | 9 | 2001 | 42 | 0.440 |
Why?
|
Benzamides | 5 | 2010 | 1369 | 0.430 |
Why?
|
Animals | 131 | 2019 | 167531 | 0.420 |
Why?
|
Pyridines | 7 | 2010 | 2876 | 0.420 |
Why?
|
Veterinary Medicine | 1 | 2011 | 21 | 0.400 |
Why?
|
Drug Interactions | 14 | 2009 | 1422 | 0.380 |
Why?
|
Receptors, Opioid, kappa | 3 | 2009 | 138 | 0.370 |
Why?
|
Xanthines | 4 | 1997 | 122 | 0.370 |
Why?
|
Dizocilpine Maleate | 2 | 2008 | 172 | 0.360 |
Why?
|
Narcotic Antagonists | 5 | 2009 | 580 | 0.360 |
Why?
|
Methamphetamine | 1 | 2012 | 163 | 0.350 |
Why?
|
Adenosine | 7 | 1990 | 832 | 0.350 |
Why?
|
Naloxone | 4 | 2009 | 368 | 0.340 |
Why?
|
Macaca mulatta | 9 | 2011 | 2315 | 0.340 |
Why?
|
Benzimidazoles | 3 | 2010 | 858 | 0.340 |
Why?
|
Haplorhini | 11 | 2005 | 529 | 0.310 |
Why?
|
GABA Modulators | 5 | 2002 | 109 | 0.300 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2007 | 69 | 0.290 |
Why?
|
Substance Abuse, Intravenous | 2 | 2009 | 529 | 0.280 |
Why?
|
Quinolines | 1 | 2012 | 758 | 0.280 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 4 | 2000 | 54 | 0.280 |
Why?
|
Substance-Related Disorders | 6 | 2011 | 4358 | 0.260 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2006 | 143 | 0.260 |
Why?
|
Lisuride | 2 | 2003 | 3 | 0.250 |
Why?
|
Morphine | 7 | 2019 | 656 | 0.250 |
Why?
|
Receptors, GABA-A | 8 | 2005 | 621 | 0.250 |
Why?
|
Infusions, Intravenous | 2 | 2011 | 2234 | 0.250 |
Why?
|
Oxazines | 6 | 2010 | 340 | 0.250 |
Why?
|
Receptors, Opioid, delta | 2 | 2009 | 48 | 0.250 |
Why?
|
Neurotransmitter Uptake Inhibitors | 4 | 1995 | 36 | 0.240 |
Why?
|
Dopamine Agents | 3 | 2002 | 189 | 0.240 |
Why?
|
Benzazepines | 6 | 2007 | 311 | 0.240 |
Why?
|
GABA-A Receptor Agonists | 5 | 2005 | 86 | 0.230 |
Why?
|
Hydrocortisone | 4 | 2007 | 1796 | 0.230 |
Why?
|
Benzodiazepinones | 4 | 1992 | 50 | 0.230 |
Why?
|
Cebinae | 1 | 2003 | 1 | 0.230 |
Why?
|
Clonidine | 5 | 2007 | 170 | 0.230 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2004 | 174 | 0.230 |
Why?
|
Macaca fascicularis | 11 | 2015 | 899 | 0.220 |
Why?
|
Drug-Seeking Behavior | 2 | 2015 | 46 | 0.220 |
Why?
|
Saliva | 2 | 2007 | 816 | 0.210 |
Why?
|
Electroshock | 14 | 1991 | 121 | 0.210 |
Why?
|
Male | 100 | 2019 | 358602 | 0.200 |
Why?
|
Benzopyrans | 3 | 2010 | 63 | 0.200 |
Why?
|
Putamen | 5 | 1994 | 291 | 0.200 |
Why?
|
Receptors, Drug | 6 | 1992 | 157 | 0.200 |
Why?
|
Benzodiazepines | 7 | 2002 | 1131 | 0.200 |
Why?
|
Nicotine | 7 | 1983 | 677 | 0.200 |
Why?
|
Food | 7 | 2003 | 773 | 0.200 |
Why?
|
Receptors, Purinergic | 5 | 1990 | 66 | 0.200 |
Why?
|
Caudate Nucleus | 5 | 1994 | 389 | 0.200 |
Why?
|
Dopamine | 8 | 2009 | 1582 | 0.190 |
Why?
|
Rats, Wistar | 6 | 2015 | 1846 | 0.190 |
Why?
|
Flumazenil | 9 | 2002 | 84 | 0.180 |
Why?
|
Amino Acids | 1 | 2006 | 1715 | 0.170 |
Why?
|
Drug Partial Agonism | 1 | 2019 | 24 | 0.170 |
Why?
|
Disease Models, Animal | 9 | 2015 | 18094 | 0.170 |
Why?
|
Pituitary-Adrenal System | 1 | 2003 | 550 | 0.170 |
Why?
|
Cues | 4 | 2015 | 867 | 0.170 |
Why?
|
Dibenzazepines | 3 | 1985 | 26 | 0.160 |
Why?
|
Fentanyl | 2 | 1999 | 429 | 0.160 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2003 | 699 | 0.160 |
Why?
|
Receptors, AMPA | 2 | 2015 | 323 | 0.160 |
Why?
|
Flupenthixol | 3 | 2007 | 11 | 0.160 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 4 | 2010 | 414 | 0.160 |
Why?
|
Long-Term Potentiation | 2 | 2010 | 293 | 0.160 |
Why?
|
Specimen Handling | 1 | 2003 | 707 | 0.160 |
Why?
|
Primates | 3 | 2008 | 524 | 0.150 |
Why?
|
Caffeine | 6 | 1989 | 701 | 0.150 |
Why?
|
Neuropeptides | 1 | 2004 | 941 | 0.150 |
Why?
|
Lorazepam | 3 | 1988 | 154 | 0.150 |
Why?
|
Histamine H1 Antagonists | 2 | 1988 | 100 | 0.140 |
Why?
|
Psychomotor Performance | 4 | 2010 | 1876 | 0.140 |
Why?
|
Reaction Time | 7 | 2003 | 2075 | 0.140 |
Why?
|
Wakefulness | 1 | 2003 | 1253 | 0.130 |
Why?
|
Membrane Glycoproteins | 2 | 2004 | 3684 | 0.130 |
Why?
|
Prazosin | 2 | 2007 | 95 | 0.130 |
Why?
|
Carrier Proteins | 7 | 2004 | 4938 | 0.130 |
Why?
|
Motor Activity | 6 | 2006 | 2687 | 0.130 |
Why?
|
Carbolines | 4 | 2002 | 288 | 0.130 |
Why?
|
Quinpirole | 2 | 2007 | 32 | 0.130 |
Why?
|
Stem Cell Transplantation | 2 | 2015 | 1603 | 0.130 |
Why?
|
Analgesics, Opioid | 4 | 2019 | 3759 | 0.130 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 1 | 2015 | 31 | 0.130 |
Why?
|
Diazepam | 6 | 2000 | 215 | 0.120 |
Why?
|
Social Environment | 2 | 1999 | 1019 | 0.120 |
Why?
|
Heroin Dependence | 2 | 2008 | 172 | 0.120 |
Why?
|
Rats | 13 | 2015 | 23577 | 0.120 |
Why?
|
Dextroamphetamine | 5 | 1987 | 134 | 0.120 |
Why?
|
Amphetamine | 2 | 2010 | 224 | 0.120 |
Why?
|
N-Methylaspartate | 1 | 1995 | 231 | 0.120 |
Why?
|
Eating | 1 | 2001 | 1537 | 0.120 |
Why?
|
Theophylline | 3 | 1989 | 131 | 0.120 |
Why?
|
Macaca | 2 | 2002 | 409 | 0.120 |
Why?
|
Stress, Psychological | 2 | 2007 | 4429 | 0.120 |
Why?
|
Phenylisopropyladenosine | 4 | 1988 | 14 | 0.120 |
Why?
|
Phosphodiesterase Inhibitors | 2 | 1997 | 215 | 0.120 |
Why?
|
Nalbuphine | 2 | 2004 | 20 | 0.120 |
Why?
|
Alfentanil | 2 | 2004 | 27 | 0.120 |
Why?
|
Corticotropin-Releasing Hormone | 2 | 2007 | 361 | 0.110 |
Why?
|
Clozapine | 5 | 1986 | 506 | 0.110 |
Why?
|
Fluoxetine | 4 | 2015 | 733 | 0.110 |
Why?
|
Mecamylamine | 6 | 1983 | 27 | 0.110 |
Why?
|
Stimulation, Chemical | 3 | 2006 | 306 | 0.110 |
Why?
|
Prefrontal Cortex | 3 | 2010 | 2210 | 0.110 |
Why?
|
Mesencephalon | 1 | 2015 | 332 | 0.110 |
Why?
|
1-Methyl-3-isobutylxanthine | 2 | 1989 | 100 | 0.100 |
Why?
|
Pyrazoles | 3 | 1988 | 1989 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2015 | 1845 | 0.100 |
Why?
|
Cholecystokinin | 1 | 1992 | 117 | 0.100 |
Why?
|
Levodopa | 2 | 2009 | 217 | 0.100 |
Why?
|
Imidazolidines | 1 | 2011 | 38 | 0.100 |
Why?
|
Indoles | 4 | 2015 | 1828 | 0.100 |
Why?
|
Muscle Rigidity | 2 | 2003 | 40 | 0.100 |
Why?
|
Adenosine-5'-(N-ethylcarboxamide) | 5 | 1990 | 15 | 0.100 |
Why?
|
Animal Husbandry | 1 | 2011 | 64 | 0.100 |
Why?
|
Buprenorphine | 1 | 2019 | 646 | 0.100 |
Why?
|
Spiro Compounds | 1 | 2011 | 68 | 0.100 |
Why?
|
Drug Synergism | 3 | 2007 | 1752 | 0.100 |
Why?
|
Pentobarbital | 3 | 1985 | 153 | 0.090 |
Why?
|
Habituation, Psychophysiologic | 1 | 2011 | 147 | 0.090 |
Why?
|
Thiophenes | 2 | 2007 | 587 | 0.090 |
Why?
|
Parkinson Disease, Secondary | 3 | 1998 | 122 | 0.090 |
Why?
|
Benzofurans | 2 | 2009 | 142 | 0.090 |
Why?
|
Citalopram | 3 | 2009 | 402 | 0.090 |
Why?
|
Parkinson Disease | 2 | 2015 | 2843 | 0.090 |
Why?
|
Drug Administration Schedule | 3 | 2009 | 4893 | 0.080 |
Why?
|
Haloperidol | 3 | 1988 | 389 | 0.080 |
Why?
|
Antimetabolites | 1 | 2010 | 127 | 0.080 |
Why?
|
Protein Subunits | 2 | 2005 | 944 | 0.080 |
Why?
|
Protein Phosphatase 1 | 1 | 2009 | 135 | 0.080 |
Why?
|
Cycloserine | 1 | 2010 | 118 | 0.080 |
Why?
|
Equipment Failure | 1 | 2011 | 577 | 0.080 |
Why?
|
Pyrrolidines | 2 | 2009 | 336 | 0.080 |
Why?
|
Pain Measurement | 1 | 2019 | 3511 | 0.080 |
Why?
|
Catheters, Indwelling | 1 | 2011 | 428 | 0.080 |
Why?
|
Glycine | 1 | 2012 | 662 | 0.080 |
Why?
|
Punishment | 2 | 1980 | 95 | 0.080 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2009 | 165 | 0.080 |
Why?
|
Respiration | 2 | 1997 | 1649 | 0.080 |
Why?
|
Antiparkinson Agents | 1 | 2009 | 183 | 0.080 |
Why?
|
Vocalization, Animal | 2 | 2010 | 93 | 0.080 |
Why?
|
Membrane Transport Proteins | 2 | 2004 | 1035 | 0.080 |
Why?
|
Secondary Prevention | 2 | 2006 | 1550 | 0.080 |
Why?
|
Grooming | 1 | 2007 | 38 | 0.070 |
Why?
|
Apomorphine | 1 | 2007 | 149 | 0.070 |
Why?
|
Drug Combinations | 3 | 2001 | 2021 | 0.070 |
Why?
|
Oxazoles | 1 | 1988 | 197 | 0.070 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2007 | 91 | 0.070 |
Why?
|
Rodentia | 1 | 2008 | 260 | 0.070 |
Why?
|
Pluripotent Stem Cells | 1 | 2013 | 791 | 0.070 |
Why?
|
Isoxazoles | 1 | 1988 | 229 | 0.070 |
Why?
|
Parkinsonian Disorders | 1 | 2009 | 283 | 0.070 |
Why?
|
Dendritic Spines | 1 | 2008 | 243 | 0.070 |
Why?
|
Vasodilator Agents | 1 | 1990 | 976 | 0.070 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2007 | 186 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1268 | 0.070 |
Why?
|
Convulsants | 1 | 1986 | 70 | 0.070 |
Why?
|
Recurrence | 4 | 2004 | 8465 | 0.070 |
Why?
|
Propranolol | 1 | 2007 | 489 | 0.060 |
Why?
|
Drug Administration Routes | 1 | 2005 | 150 | 0.060 |
Why?
|
Serotonin | 2 | 2009 | 1034 | 0.060 |
Why?
|
Cardiovascular System | 2 | 1997 | 849 | 0.060 |
Why?
|
Binding, Competitive | 6 | 1996 | 1143 | 0.060 |
Why?
|
Angiotensin II | 1 | 1988 | 850 | 0.060 |
Why?
|
Vesicular Biogenic Amine Transport Proteins | 1 | 2004 | 9 | 0.060 |
Why?
|
Receptors, Biogenic Amine | 1 | 2004 | 4 | 0.060 |
Why?
|
Yohimbine | 1 | 2004 | 62 | 0.060 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2003 | 19 | 0.060 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2004 | 43 | 0.060 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 1 | 2004 | 66 | 0.060 |
Why?
|
Morphine Derivatives | 1 | 2003 | 42 | 0.060 |
Why?
|
Membrane Transport Modulators | 1 | 2003 | 24 | 0.060 |
Why?
|
Equipment Design | 1 | 2011 | 3529 | 0.060 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2004 | 178 | 0.050 |
Why?
|
Vasoconstrictor Agents | 1 | 2007 | 651 | 0.050 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2003 | 202 | 0.050 |
Why?
|
Neurons | 3 | 2013 | 9410 | 0.050 |
Why?
|
Tranquilizing Agents | 1 | 1983 | 58 | 0.050 |
Why?
|
Exploratory Behavior | 1 | 2004 | 273 | 0.050 |
Why?
|
Blood-Brain Barrier | 1 | 2009 | 1015 | 0.050 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 1 | 2003 | 89 | 0.050 |
Why?
|
Cebidae | 1 | 1982 | 21 | 0.050 |
Why?
|
Female | 19 | 2013 | 390174 | 0.050 |
Why?
|
Stereoisomerism | 5 | 1992 | 618 | 0.050 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2004 | 324 | 0.050 |
Why?
|
Azabicyclo Compounds | 3 | 1987 | 68 | 0.050 |
Why?
|
Piperidines | 1 | 2010 | 1648 | 0.050 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1988 | 1132 | 0.050 |
Why?
|
Muscle Contraction | 1 | 2006 | 1201 | 0.050 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2003 | 619 | 0.050 |
Why?
|
Symporters | 1 | 2004 | 361 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2004 | 4409 | 0.050 |
Why?
|
Catalepsy | 1 | 2000 | 31 | 0.050 |
Why?
|
Barbiturates | 1 | 2001 | 113 | 0.040 |
Why?
|
Models, Economic | 1 | 2004 | 717 | 0.040 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 4 | 2009 | 90 | 0.040 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 1999 | 20 | 0.040 |
Why?
|
Ataxia | 1 | 2002 | 305 | 0.040 |
Why?
|
Nucleus Accumbens | 1 | 2002 | 365 | 0.040 |
Why?
|
Propiophenones | 2 | 1989 | 28 | 0.040 |
Why?
|
Pyridazines | 3 | 2002 | 200 | 0.040 |
Why?
|
GABA Antagonists | 3 | 2005 | 120 | 0.040 |
Why?
|
Phenanthridines | 2 | 1996 | 51 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2694 | 0.040 |
Why?
|
Acetamides | 1 | 2000 | 256 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2004 | 1019 | 0.040 |
Why?
|
Ethanol | 1 | 2005 | 1314 | 0.040 |
Why?
|
2-Chloroadenosine | 2 | 1988 | 11 | 0.040 |
Why?
|
Oxycodone | 1 | 2019 | 138 | 0.040 |
Why?
|
Conditioning, Classical | 1 | 2000 | 363 | 0.040 |
Why?
|
Structure-Activity Relationship | 4 | 2003 | 3087 | 0.040 |
Why?
|
Cyproheptadine | 2 | 1988 | 20 | 0.040 |
Why?
|
Purinergic P1 Receptor Antagonists | 1 | 1997 | 45 | 0.040 |
Why?
|
Carbon Radioisotopes | 2 | 1998 | 557 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2002 | 1343 | 0.040 |
Why?
|
Bupropion | 2 | 1989 | 304 | 0.030 |
Why?
|
Tripelennamine | 2 | 1986 | 6 | 0.030 |
Why?
|
Brain | 8 | 2009 | 26860 | 0.030 |
Why?
|
Receptors, Purinergic P1 | 1 | 1997 | 108 | 0.030 |
Why?
|
Nordazepam | 2 | 1986 | 5 | 0.030 |
Why?
|
Anesthetics, Local | 2 | 2002 | 1001 | 0.030 |
Why?
|
Diphenhydramine | 2 | 1986 | 63 | 0.030 |
Why?
|
Reward | 1 | 2003 | 954 | 0.030 |
Why?
|
Adrenergic Antagonists | 1 | 1995 | 26 | 0.030 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2015 | 70 | 0.030 |
Why?
|
Ergolines | 1 | 1995 | 57 | 0.030 |
Why?
|
Ethylamines | 1 | 2015 | 17 | 0.030 |
Why?
|
Adrenergic Agonists | 1 | 1995 | 58 | 0.030 |
Why?
|
Receptors, Adrenergic, alpha | 1 | 1995 | 146 | 0.030 |
Why?
|
Time Factors | 7 | 2009 | 40083 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2004 | 6239 | 0.030 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 1997 | 239 | 0.030 |
Why?
|
Phenethylamines | 1 | 1995 | 95 | 0.030 |
Why?
|
Blood Pressure | 2 | 1988 | 8520 | 0.030 |
Why?
|
Radioligand Assay | 2 | 1992 | 365 | 0.030 |
Why?
|
GABA-A Receptor Antagonists | 2 | 2005 | 60 | 0.030 |
Why?
|
Environment | 2 | 2015 | 1118 | 0.030 |
Why?
|
Cyclic AMP | 1 | 1997 | 1456 | 0.030 |
Why?
|
Devazepide | 1 | 1992 | 4 | 0.030 |
Why?
|
Receptors, Cholecystokinin | 1 | 1992 | 18 | 0.030 |
Why?
|
Hexamethonium Compounds | 2 | 1983 | 23 | 0.030 |
Why?
|
Pyrimidines | 2 | 2000 | 2996 | 0.030 |
Why?
|
Binding Sites | 3 | 1991 | 6054 | 0.030 |
Why?
|
Meglumine | 1 | 1992 | 145 | 0.030 |
Why?
|
Salicylamides | 1 | 1991 | 33 | 0.020 |
Why?
|
Columbidae | 3 | 1985 | 39 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 1999 | 1177 | 0.020 |
Why?
|
Chlorpromazine | 2 | 1983 | 111 | 0.020 |
Why?
|
Indans | 1 | 1992 | 91 | 0.020 |
Why?
|
Midazolam | 2 | 1999 | 268 | 0.020 |
Why?
|
Aminopyridines | 1 | 2015 | 564 | 0.020 |
Why?
|
Mitosis | 1 | 1996 | 1195 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2006 | 4922 | 0.020 |
Why?
|
Nortropanes | 1 | 1990 | 12 | 0.020 |
Why?
|
Mazindol | 1 | 1989 | 13 | 0.020 |
Why?
|
Nomifensine | 1 | 1989 | 14 | 0.020 |
Why?
|
Synaptic Transmission | 2 | 2009 | 1169 | 0.020 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2010 | 241 | 0.020 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2009 | 42 | 0.020 |
Why?
|
Biogenic Monoamines | 1 | 1989 | 50 | 0.020 |
Why?
|
Synapses | 2 | 2009 | 1748 | 0.020 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2010 | 369 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 2393 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 1989 | 553 | 0.020 |
Why?
|
Nerve Fibers | 1 | 1992 | 708 | 0.020 |
Why?
|
Desipramine | 1 | 1988 | 182 | 0.020 |
Why?
|
Tomography, Emission-Computed | 3 | 1998 | 1121 | 0.020 |
Why?
|
Extracellular Space | 1 | 2009 | 565 | 0.020 |
Why?
|
Locomotion | 1 | 2010 | 386 | 0.020 |
Why?
|
Phenylephrine | 1 | 1988 | 292 | 0.020 |
Why?
|
Isomerism | 1 | 1987 | 197 | 0.020 |
Why?
|
Pyramidal Cells | 1 | 2009 | 369 | 0.020 |
Why?
|
Chlorpheniramine | 1 | 1986 | 13 | 0.020 |
Why?
|
Sulfur Compounds | 1 | 1987 | 33 | 0.020 |
Why?
|
Promethazine | 1 | 1986 | 29 | 0.020 |
Why?
|
Cimetidine | 1 | 1986 | 76 | 0.020 |
Why?
|
Barbital | 1 | 1985 | 1 | 0.020 |
Why?
|
Cinanserin | 1 | 1985 | 1 | 0.020 |
Why?
|
Ligands | 2 | 2009 | 3272 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 1992 | 882 | 0.020 |
Why?
|
Theobromine | 1 | 1985 | 14 | 0.020 |
Why?
|
Mutation | 1 | 2010 | 29878 | 0.020 |
Why?
|
Naphthyridines | 1 | 1987 | 141 | 0.020 |
Why?
|
Muscimol | 1 | 1985 | 70 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2009 | 826 | 0.020 |
Why?
|
Heart Rate | 2 | 1988 | 4165 | 0.020 |
Why?
|
Phenazocine | 1 | 1985 | 7 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2012 | 64867 | 0.020 |
Why?
|
Loxapine | 1 | 1985 | 3 | 0.020 |
Why?
|
Methylphenidate | 1 | 1989 | 483 | 0.020 |
Why?
|
Buspirone | 1 | 1985 | 81 | 0.020 |
Why?
|
Humans | 12 | 2015 | 759098 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2010 | 14333 | 0.020 |
Why?
|
Signal Transduction | 1 | 2008 | 23328 | 0.010 |
Why?
|
Dibenzothiazepines | 1 | 1985 | 102 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2009 | 893 | 0.010 |
Why?
|
Phosphorylation | 1 | 2015 | 8312 | 0.010 |
Why?
|
Avoidance Learning | 1 | 1986 | 248 | 0.010 |
Why?
|
Biogenic Amines | 1 | 2003 | 53 | 0.010 |
Why?
|
Thioridazine | 1 | 1983 | 33 | 0.010 |
Why?
|
Flunitrazepam | 1 | 2002 | 20 | 0.010 |
Why?
|
Premedication | 1 | 1983 | 254 | 0.010 |
Why?
|
Alprazolam | 1 | 2002 | 101 | 0.010 |
Why?
|
Feeding Behavior | 2 | 1986 | 3183 | 0.010 |
Why?
|
Septum of Brain | 1 | 2002 | 18 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2010 | 21892 | 0.010 |
Why?
|
Models, Neurological | 1 | 2009 | 1757 | 0.010 |
Why?
|
Microinjections | 1 | 2002 | 321 | 0.010 |
Why?
|
Neostriatum | 1 | 2002 | 246 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1996 | 18937 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7583 | 0.010 |
Why?
|
Appetitive Behavior | 1 | 1979 | 39 | 0.010 |
Why?
|
Mice | 4 | 2010 | 80993 | 0.010 |
Why?
|
Autoradiography | 2 | 1991 | 730 | 0.010 |
Why?
|
Air Pressure | 1 | 1979 | 74 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2008 | 1428 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1981 | 1312 | 0.010 |
Why?
|
Cell Membrane | 1 | 2008 | 3682 | 0.010 |
Why?
|
Lactates | 1 | 1998 | 404 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2002 | 1166 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 1990 | 3060 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1985 | 2821 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11461 | 0.010 |
Why?
|
Social Behavior | 1 | 2002 | 1130 | 0.010 |
Why?
|
Steroids | 1 | 2000 | 927 | 0.010 |
Why?
|
Nerve Endings | 1 | 1994 | 105 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 1998 | 748 | 0.010 |
Why?
|
Sleep | 1 | 2010 | 4734 | 0.010 |
Why?
|
Central Nervous System Stimulants | 1 | 2002 | 1169 | 0.010 |
Why?
|
Corpus Striatum | 1 | 1998 | 1232 | 0.010 |
Why?
|
Choice Behavior | 1 | 1978 | 817 | 0.010 |
Why?
|
Tritium | 1 | 1991 | 707 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8147 | 0.010 |
Why?
|
Pharmaceutical Preparations | 1 | 1978 | 1093 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1998 | 3761 | 0.000 |
Why?
|
Tissue Distribution | 1 | 1991 | 2262 | 0.000 |
Why?
|
Models, Statistical | 1 | 2002 | 5067 | 0.000 |
Why?
|
Phencyclidine | 1 | 1985 | 60 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36164 | 0.000 |
Why?
|
Kinetics | 1 | 1989 | 6373 | 0.000 |
Why?
|
Species Specificity | 1 | 1983 | 2408 | 0.000 |
Why?
|
Synaptosomes | 1 | 1978 | 115 | 0.000 |
Why?
|
Adult | 1 | 2013 | 219353 | 0.000 |
Why?
|
Dogs | 1 | 1983 | 3839 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1992 | 11046 | 0.000 |
Why?
|
Drinking | 1 | 1978 | 199 | 0.000 |
Why?
|
Smoking | 1 | 1983 | 9066 | 0.000 |
Why?
|